Please view the full content in the pdf above.
Chemotherapy and New Drugs in Prostate Cancer
N.M. has received grants or research support from Takeda/Millenium, Astellas, Pierre Fabre, Sanofi, and Pasteur; and honoraria or consultation fees from Takeda/Millenium, Jansen, Astellas, BMS, Bayer, IPSEN, Ferring, Novartis, Nuclétron, Pierre Fabre, Sanofi, and AstraZeneca.
- EMJ Urol. 2015;3:103-110.
Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.